Administrative Core
行政核心
基本信息
- 批准号:10703343
- 负责人:
- 金额:$ 12.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-12 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdministratorAdvisory CommitteesAntibiotic TherapyAntimicrobial ResistanceAwardBioinformaticsBudgetsCellsClinicalCollaborationsCombating Antibiotic Resistant BacteriaCommunicationCritiquesDataEnsureEvaluationEventFailureGenomicsGoalsGuidelinesHuman ResourcesIndividualIntellectual PropertyInterdisciplinary StudyLaboratoriesLeadershipLightMentorsMutationNational Institute of Allergy and Infectious DiseaseOccupational activity of managing financesPatientsPerformancePersonsPlayPrincipal InvestigatorProgress ReportsResearchResearch PersonnelResearch Project GrantsResistanceResourcesRoleRouteServicesStudentsSuggestionTechnology TransferTrainingTravelTreatment FailureU-Series Cooperative AgreementsVisionclinical materialmeetingsnew technologyoperationprogramssuccesssymposiumsynergismvirtual
项目摘要
The Administrative Core of the Interdisciplinary Research Unit for Attacking Failure of Antibiotic Treatment
(AFAT) will oversee the day-to-day operations of the Unit, ensuring that the scientific Aims of the Unit are met.
The Core Director, Dr. Tim van Opijnen, will oversee the Core in collaboration with an administrator and a
Synergy Director, Dr. Ralph Isberg. Milestone tracking will be an important duty of the Administrative Core,
and a defined set of these goals has been established to facilitate the timely completion of Specific Aims
detailed in three Research Projects and one Scientific Core. A second important duty will be ensuring scientific
synergy as well as technology transfer between individual projects and the Scientific Core. There will be a
Mentoring Plan established to allow students and fellows to be collaboratively guided within the three Projects,
with special emphasis on bioinformatic training provided by the Scientific Core. An external Scientific Advisory
Board will provide guidance on the conduct of the Unit, including critiques of spending plans and evaluation of
progress toward effective implementation of synergistic relationships. Another important role of the Board will
be to evaluate progress toward milestones, and provide suggestions regarding alternate routes of attacking
problems, when needed. A key responsibility of the Core will be to communicate with NIAID officials regarding
progress in the Unit, as well as organize, prepare and submit annual progress reports. The Core will also plan
for annual meetings attended by other Combatting Antibiotic Resistant Bacteria Interdisciplinary Units
(CARBIRU) and provide resources for travel for of the Team to these annual meetings.
抗生素治疗攻击失败的跨学科研究部门的行政核心
(AFAT)将监督该部门的日常运营,以确保满足该单元的科学目标。
核心主任蒂姆·范·奥普尼(Tim van Opijnen)博士将与管理员合作监督核心
协同主任拉尔夫·伊斯伯格(Ralph Isberg)博士。里程碑跟踪将是行政核心的重要职责,
并且已经建立了一组这些目标,以促进及时完成特定目标
在三个研究项目和一个科学核心中详细介绍。第二个重要职责将确保科学
单个项目与科学核心之间的协同作用以及技术转移。会有一个
建立的指导计划允许学生和研究员在三个项目中进行协作指导,
特别强调科学核心提供的生物信息学培训。外部科学咨询
董事会将提供有关单位行为的指导,包括对支出计划的批评和评估
有效实施协同关系的进展。董事会的另一个重要角色将
要评估对里程碑的进度,并提供有关替代攻击途径的建议
问题,需要时。核心的关键责任是与NIAID官员就
该单位的进度以及组织,准备和提交年度进度报告。核心也将计划
对于其他对抗抗生素抗生素跨学科单元参加的年度会议
(Carbiru)并为团队提供这些年度会议的旅行资源。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Tim van Opijnen其他文献
Tim van Opijnen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Tim van Opijnen', 18)}}的其他基金
A blind source separation approach for deconvolution of bulk transcriptional data leads to early detection of ATF cell-states in complex bacterial populations, in vitro and in vivo
用于批量转录数据去卷积的盲源分离方法可以在体外和体内早期检测复杂细菌群体中的 ATF 细胞状态
- 批准号:
10703357 - 财政年份:2022
- 资助金额:
$ 12.4万 - 项目类别:
A priori adaptive evolution predictions for antibiotic resistance through genome-wide network analyses and machine learning
通过全基因组网络分析和机器学习对抗生素耐药性进行先验适应性进化预测
- 批准号:
10155396 - 财政年份:2020
- 资助金额:
$ 12.4万 - 项目类别:
Predicting species-wide virulence for a bacterial pathogen with a large pan-genome
预测具有大型泛基因组的细菌病原体的物种范围毒力
- 批准号:
9199847 - 财政年份:2016
- 资助金额:
$ 12.4万 - 项目类别:
相似海外基金
Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy Outcomes
通过移动电话 (m-MIST TM) 提供医疗信息服务以改善妊娠结果
- 批准号:
10705809 - 财政年份:2022
- 资助金额:
$ 12.4万 - 项目类别:
Technology-Enhanced Asthma Care in Children at Clinic and Home (TEACCCH) Study
技术增强的儿童哮喘护理诊所和家庭 (TEACCCH) 研究
- 批准号:
10369968 - 财政年份:2022
- 资助金额:
$ 12.4万 - 项目类别:
Medical Information Service via mobile Telephone (m-MIST TM) Provider Support to Improve Pregnancy Outcomes
通过移动电话 (m-MIST TM) 提供医疗信息服务以改善妊娠结果
- 批准号:
10672690 - 财政年份:2022
- 资助金额:
$ 12.4万 - 项目类别:
Technology-Enhanced Asthma Care in Children at Clinic and Home (TEACCCH) Study
技术增强的儿童哮喘护理诊所和家庭 (TEACCCH) 研究
- 批准号:
10580783 - 财政年份:2022
- 资助金额:
$ 12.4万 - 项目类别: